186 related articles for article (PubMed ID: 38743422)
1. Exploring Anabolic Androgenic Steroid Use Among Cisgender Gay, Bisexual, and Queer Men.
Kutscher E; Arshed A; Greene RE; Kladney M
JAMA Netw Open; 2024 May; 7(5):e2411088. PubMed ID: 38743422
[TBL] [Abstract][Full Text] [Related]
2. Sources of knowledge and truth related to anabolic/androgenic steroid use among two-spirit, gay, bisexual, queer, and other men who have sex with men.
Star J
Can J Public Health; 2023 Apr; 114(2):308-316. PubMed ID: 36068433
[TBL] [Abstract][Full Text] [Related]
3. The CASTRO study: Unsafe sexual behaviors and illicit drug use among gay and bisexual men who use anabolic steroids.
Ip EJ; Doroudgar S; Shah-Manek B; Barnett MJ; Tenerowicz MJ; Ortanez M; Pope HG
Am J Addict; 2019 Feb; 28(2):101-110. PubMed ID: 30724428
[TBL] [Abstract][Full Text] [Related]
4. Anabolic steroid use among gay and bisexual men living in Australia and New Zealand: Associations with demographics, body dissatisfaction, eating disorder psychopathology, and quality of life.
Griffiths S; Murray SB; Dunn M; Blashill AJ
Drug Alcohol Depend; 2017 Dec; 181():170-176. PubMed ID: 29055822
[TBL] [Abstract][Full Text] [Related]
5. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters.
Scarth M; Westlye LT; Havnes IA; Bjørnebekk A
BMC Psychiatry; 2023 May; 23(1):342. PubMed ID: 37193971
[TBL] [Abstract][Full Text] [Related]
6. Community norms of the Muscle Dysmorphic Disorder Inventory (MDDI) among cisgender sexual minority men and women.
Nagata JM; Compte EJ; Cattle CJ; Lavender JM; Brown TA; Murray SB; Flentje A; Capriotti MR; Lubensky ME; Obedin-Maliver J; Lunn MR
BMC Psychiatry; 2021 Jun; 21(1):297. PubMed ID: 34103034
[TBL] [Abstract][Full Text] [Related]
7. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.
Henriksen HCB; Havnes IA; Jørstad ML; Bjørnebekk A
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):19. PubMed ID: 37013635
[TBL] [Abstract][Full Text] [Related]
8. Machismo and anabolic steroid misuse among young Latino sexual minority men.
Brady JP; Kimball D; Mendenhall B; Blashill AJ
Body Image; 2019 Sep; 30():165-169. PubMed ID: 31374390
[TBL] [Abstract][Full Text] [Related]
9. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
10. Gendered perspectives on women's anabolic-androgenic steroid (AAS) usage practices.
Piatkowski T; Robertson J; Lamon S; Dunn M
Harm Reduct J; 2023 Apr; 20(1):56. PubMed ID: 37098574
[TBL] [Abstract][Full Text] [Related]
11. Norms and normalisation: understanding lesbian, gay, bisexual, transgender and queer youth, suicidality and help-seeking.
McDermott E; Hughes E; Rawlings V
Cult Health Sex; 2018 Feb; 20(2):156-172. PubMed ID: 28641479
[TBL] [Abstract][Full Text] [Related]
12. A lesbian, gay, bisexual and transgender dedicated inpatient psychiatric unit in rural New England: a descriptive analysis in demographics, service utilisation and needs.
Klotzbaugh R; Glover E
J Clin Nurs; 2016 Dec; 25(23-24):3570-3576. PubMed ID: 27241882
[TBL] [Abstract][Full Text] [Related]
13. The awareness and experience of healthcare providers with the use of anabolic androgenic steroids by gym users.
Izzat N; Abu-Farha R; Al-Mestarihi E; Alzoubi KH
Int J Legal Med; 2023 Nov; 137(6):1705-1711. PubMed ID: 37624373
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men.
Johnson MJ; Mueller M; Eliason MJ; Stuart G; Nemeth LS
J Clin Nurs; 2016 Dec; 25(23-24):3628-3642. PubMed ID: 27240268
[TBL] [Abstract][Full Text] [Related]
15. Psychological and physical impact of anabolic-androgenic steroid dependence.
Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
[TBL] [Abstract][Full Text] [Related]
16. Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review.
Bonnecaze AK; O'Connor T; Burns CA
J Gen Intern Med; 2021 Jul; 36(7):2055-2064. PubMed ID: 33948794
[TBL] [Abstract][Full Text] [Related]
17. Social Support-Seeking Strategies on Social Media at the Intersection of Lesbian, Gay, Bisexual, Transgender, and Queer Identity, Race, and Ethnicity: Insights for Intervention From a Qualitative Study.
Gordon JD; Whitfield DL; Mammadli T; Escobar-Viera CG
JMIR Form Res; 2023 Oct; 7():e51702. PubMed ID: 37862069
[TBL] [Abstract][Full Text] [Related]
18. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.
Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B
Drug Alcohol Rev; 2018 Jul; 37(5):664-670. PubMed ID: 29484740
[TBL] [Abstract][Full Text] [Related]
19. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
[TBL] [Abstract][Full Text] [Related]
20. Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters.
Jørstad ML; Scarth M; Torgersen S; Pope HG; Bjørnebekk A
Brain Behav; 2023 Jul; 13(7):e3040. PubMed ID: 37150843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
